Viewing Study NCT03284502


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-03-05 @ 11:37 AM
Study NCT ID: NCT03284502
Status: UNKNOWN
Last Update Posted: 2023-08-01
First Post: 2017-08-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-05-22
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2017-08-07
First Submit QC Date: None
Study First Post Date: 2017-09-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-28
Last Update Post Date: 2023-08-01
Last Update Post Date Type: ACTUAL